Primary Record
olafertinib
- In stock
- 2,270 g
- Purity
- 99.1 %
- CAS
- 1660963-42-7
Compound Identifiers & Properties
- CAS
- 1660963-42-7
- PubChem CID
- 117909640
- SMILES
- C=CC(=O)NC1=CC=CC(=C1)C2=CC=CC3=CN=C(N=C32)NC4=C(C(=C(C=C4)N5CCN(CC5)CCO)F)F
- Canonical SMILES
- C=CC(=O)Nc1cccc(-c2cccc3cnc(Nc4ccc(N5CCN(CCO)CC5)c(F)c4F)nc23)c1
Names & Synonyms
- olafertinib
- 1660963-42-7
- RX-518
- EGFR-IN-3
- OLAFERTINIB [INN]
- CK-101
- RefChem:168052
- UNII-708TLB8J3Y
- OLAFERTINIB [WHO-DD]
- N-(3-(2-((2,3-Difluoro-4-(4-(2-hydroxyethyl)piperazin-1-yl)phenyl)amino)quinazolin-8-yl)phenyl)acrylamide
- 708TLB8J3Y
- C29H28F2N6O2
- MFCD30345533
- GTPL9863
- orb1296096
- RX518
- CHEMBL4297486
- SCHEMBL16514522
- SCHEMBL29369343
- SCHEMBL29623752
- SCHEMBL30341859
- KS-00000TOQ
- IDRGFNPZDVBSSE-UHFFFAOYSA-N
- BDBM318916
- CK101
- BCP19075
- EX-A1142
- KRC96342
- CK 101
- US10172868, Compound C151
- AKOS030632731
- RX518(CK-101)
- ZINC514250913
- EGFR Mutant-specific Inhibitor CK-101
- AC-35884
- AK543910
- DS-19272
- Example 153 [US20170050936A1]
- HY-19815
- RX518(CK-101:EGFR-IN-3)?
- CS-0016788
- Example 153 (US20170050936A1)
- N-[3-[2-[2,3-difluoro-4-[4-(2-hydroxyethyl)piperazin-1-yl]anilino]quinazolin-8-yl]phenyl]prop-2-enamide
- F17404
- A911365
- 2-Propenamide, N-[3-[2-[[2,3-difluoro-4-[4-(2-hydroxyethyl)-1-piperazinyl]phenyl]amino]-8-quinazolinyl]phenyl]-
- RX 518;RX518;EGFR-IN-3;CK101;CK-101;CK 101
- 2-Propenamide, N-(3-(2-((2,3-difluoro-4-(4-(2-hydroxyethyl)-1-piperazinyl)phenyl)amino)-8-quinazolinyl)phenyl)-
- N-(3-(2-(2,3-Difluoro-4-(4-(2-hydroxyethyl)piperazin-1-yl)phenylamino)quinazolin-8-yl)phenyl)acrylamide
- 145379-14-2
- N-[3-[2-[[2,3-difluoro-4-[4-(2-hydroxyethyl)piperazin-1-yl]phenyl]amino]quinazolin-8-yl]phenyl]acrylamide
- N-{3-[2-({2,3-difluoro-4-[4-(2-hydroxyethyl)piperazin-1-yl]phenyl}amino)quinazolin-8-yl]phenyl}prop-2-enamide